SecBot SecBot
EFFECT ·Filed May 22, 2026

PALI

PALISADE BIO, INC.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC9999999995-26-001731
IPO/offering going effective
Actionable Insight • Neutral

Monitor for any subsequent prospectus supplement or takedown notice, which would signal an actual offering. The shelf becoming effective is a procedural step; the stock is unlikely to react until a specific offering is announced.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$1.95
T+0 close · May 22, 2026 · via day close
Latest settled
+4.62%
T+60 · $2.04
Vs SPY
+1.43%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 22 $1.95entry
  2. T+1 · 6mo ago +2.05%α +1.47% · $1.99
  3. T+5 · 6mo ago +6.67%α +5.01% · $2.08
  4. T+20 · 5mo ago −3.08%α −1.66% · $1.89
  5. T+60 · 3mo ago +4.62%α +1.43% · $2.04

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Palisade Bio's $300M universal shelf registration (File No. 333-295815) became effective on May 21, 2026, enabling the company to offer and sell securities at any time. The company had $132.6M in cash as of March 31, 2026, and management has stated existing cash funds operations through key Phase 2 readouts in 2H 2027 and early 2028, suggesting this is an opportunistic shelf filing rather than an imminent dilutive event.

Key Facts

  • Shelf registration (File No. 333-295815) declared effective on May 21, 2026.
  • Company reported $132.6M in cash as of March 31, 2026.
  • Management states existing cash funds operations through Phase 2 readouts in 2H 2027 and early 2028.
  • Shelf provides maximum flexibility for future capital raises but no immediate offering announced.

Financial Impact

Up to $300M in potential future offerings, but no immediate dilution as no takedown has occurred.

dilutioncash

Risk Factors

  • Potential future dilution if the company conducts an offering under the shelf.
  • Market may perceive shelf effectiveness as overhang, especially for a pre-revenue biotech.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001731
Document: 9999999995-26-001731-index.html9999999995-26-001731
Document: 9999999995-26-001731.txt9999999995-26-001731

Track record

14 reports on PALI

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.08 Now $1.03 −4.19% settles Dec 15
  2. Nov 10, 20266d ago 8-K Neutral 5/10 Entry $1.17 Now $1.03 −11.97% settles Dec 10
  3. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $1.13 Now $1.03 −8.85% settles Dec 9
  4. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $1.16 Now $1.03 −11.21% settles Nov 30
  5. Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $1.69 to $1.43 Now $1.03 −39.05% ▼ −15.38% −14.82% vs SPY
  6. Sep 22, 20267w ago Press Release Bullish 6/10 Entry $1.69 to $1.43 Now $1.03 −39.05% ▼ −15.38% −14.82% vs SPY
  7. Aug 10, 202614w ago 8-K Neutral 5/10 Entry $2.14 to $2.05 Now $1.03 −51.87% ▼ −4.21% −3.15% vs SPY
  8. Jul 10, 202618w ago Insider Cluster Neutral 2/10 Entry $1.89 to $2.10 Now $1.03 −45.50% ▲ +11.11% +7.93% vs SPY
  9. Jul 8, 202618w ago Insider Cluster Neutral 3/10 Entry $1.97 to $2.09 Now $1.03 −47.72% ▲ +6.09% +3.85% vs SPY
  10. Jun 11, 202622w ago 8-K Neutral 4/10 Entry $1.71 to $1.96 Now $1.03 −39.77% ▲ +14.62% +12.84% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 6h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 22, 2026